Another quality clear interview today from JVDW post Canadian approval.
New info is that we a “major U.S. trauma surgeon” from Massachusetts General Hospital who is also a captain in the US Navy visiting Perth in May to check out Orthocell’s facilities and meet with Aussie surgeons. You don’t see that everyday. And what that means is that first US orders are well and truly on its way to being placed very shortly.
Given the U.S. navy connection of that major surgeon, it sparked me to remind people of the U.S. Military potential use of Remplir, given the sort of wounds sustained in the military. We have Kim Beazley onto this (probably working behind the scenes now that we have approval). So it’s a watch this space (where the market opportunity is large)!
OCC Price at posting:
$1.60 Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)